SCHEMBL26870862

SCHEMBL26870862

N#Cc1cnn2c(Cl)cc(C(C3CC3)C3CC3)nc12

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 4/20 0.44
▸ KDM4E B2RXH2 5/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ CHEK1 O14757 1/20 0.39
▸ CCNA2 P20248 1/20 0.39
▸ CCNA1 P78396 1/20 0.39
▸ CSNK2A1 P68400 8/20 0.38
▸ GLA P06280 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ HTT P42858 1/20 0.36
▸ MAPKAPK2 P49137 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ BCL6 P41182 1/20 0.35
▸ KDM4D Q6B0I6 1/20 0.35
▸ KDM5A P29375 1/20 0.34
▸ KDM4C Q9H3R0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26870888 0.80 KDM4E (0.36) CDK2KDM4EALDH1A1CCNA2CCNA1
SCHEMBL26871380 0.79 CSNK2A1 (0.52) CDK2CSNK2A1BCL6
SCHEMBL26870923 0.78 CCNT1 (0.31) CDK2KDM4EALDH1A1CCNA2CCNA1
SCHEMBL26871061 0.76 PIK3CB (0.33) CDK2CCNA2CCNA1
SCHEMBL26870935 0.76 CDK2 (0.39) CDK2KDM4EALDH1A1CHEK1CCNA2
SCHEMBL15288383 0.75 CDK2 (0.61) CDK2KDM4EALDH1A1CSNK2A1GLA
SCHEMBL26867735 0.75 CCNT1 (0.56) CDK2CCNA2CCNA1CSNK2A1MAPKAPK2
SCHEMBL18343698 0.73 KDM4E (0.59) CDK2KDM4EALDH1A1CSNK2A1GLA
SCHEMBL28420899 0.71 CDK2 (0.49) CDK2KDM4EALDH1A1CSNK2A1GLA
SCHEMBL26871261 0.69 CDK2 (0.46) CDK2KDM4EALDH1A1CCNA2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4282868-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE-7-AMINE DERIVATIVE, AND COMPOSITIONS AND MEDICAL USE THEREOF Shanghai Haiyan Pharmaceutical Technology Co., Ltd (CN) 2023-11-29 — — EP disclosed
Send feedback